Compare VRXA & WEYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VRXA | WEYS |
|---|---|---|
| Founded | N/A | 1906 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 390.3M | 331.9M |
| IPO Year | N/A | 1995 |
| Metric | VRXA | WEYS |
|---|---|---|
| Price | $2.20 | $37.92 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 16.8K |
| Earning Date | N/A | 05-05-2026 |
| Dividend Yield | N/A | ★ 3.24% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.64 |
| Revenue | N/A | ★ $276,169,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $58.67 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.70 | $27.25 |
| 52 Week High | $4.50 | $39.98 |
| Indicator | VRXA | WEYS |
|---|---|---|
| Relative Strength Index (RSI) | 28.42 | 55.74 |
| Support Level | $2.05 | $30.78 |
| Resistance Level | $3.49 | $39.98 |
| Average True Range (ATR) | 0.53 | 1.23 |
| MACD | 0.00 | -0.17 |
| Stochastic Oscillator | 17.14 | 57.88 |
Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.
Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale operations and the North American retail operations. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, South Africa, and Australia.